| Dr John Markus Deleeuw, DO | |
|
509 N Madison St, Bloomfield, IA 52537-1271 | |
| (641) 664-3832 | |
| (641) 664-1857 |
| Full Name | Dr John Markus Deleeuw |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 509 N Madison St, Bloomfield, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770590846 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Regional Medical Center | Kirksville, MO | Hospital |
| Davis County Hospital | Bloomfield, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Hospitalist Physicians Llp | 9830487966 | 40 |
| Kirksville Missouri Hospital Company Llc | 3274517347 | 4 |
| Davis County Hospital | 3971493040 | 10 |
News Archive
Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
ARKRAY USA, Inc., a global leader of clinical chemistry, urine chemistry, and blood glucose products, today announced that it has re-introduced the CLIA waived DiaScreen® 50 Urine Chemistry Analyzer.
Wyatt Technology, the world leader in instrumentation for absolute macromolecular and nanoparticle characterization, reveals the launch of its 6th-generation Eclipse FFF system that represents an entirely new paradigm of FFF technology.
The Johns Hopkins University Applied Physics Laboratory, in Laurel, Maryland, has received $4 million in funding from the Mann Fund to develop a next-generation retinal prosthesis system. The Mann Fund was created by philanthropist Alfred E. Mann 15 years ago to support the development of biomedical technologies.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
› Verified 5 days ago
| Entity Name | Kirksville Clinic Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538155817 PECOS PAC ID: 4486619269 Enrollment ID: O20041122000018 |
News Archive
Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
ARKRAY USA, Inc., a global leader of clinical chemistry, urine chemistry, and blood glucose products, today announced that it has re-introduced the CLIA waived DiaScreen® 50 Urine Chemistry Analyzer.
Wyatt Technology, the world leader in instrumentation for absolute macromolecular and nanoparticle characterization, reveals the launch of its 6th-generation Eclipse FFF system that represents an entirely new paradigm of FFF technology.
The Johns Hopkins University Applied Physics Laboratory, in Laurel, Maryland, has received $4 million in funding from the Mann Fund to develop a next-generation retinal prosthesis system. The Mann Fund was created by philanthropist Alfred E. Mann 15 years ago to support the development of biomedical technologies.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
› Verified 5 days ago
| Entity Name | Kirksville Missouri Hospital Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336491448 PECOS PAC ID: 3274517347 Enrollment ID: O20130312000204 |
News Archive
Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
ARKRAY USA, Inc., a global leader of clinical chemistry, urine chemistry, and blood glucose products, today announced that it has re-introduced the CLIA waived DiaScreen® 50 Urine Chemistry Analyzer.
Wyatt Technology, the world leader in instrumentation for absolute macromolecular and nanoparticle characterization, reveals the launch of its 6th-generation Eclipse FFF system that represents an entirely new paradigm of FFF technology.
The Johns Hopkins University Applied Physics Laboratory, in Laurel, Maryland, has received $4 million in funding from the Mann Fund to develop a next-generation retinal prosthesis system. The Mann Fund was created by philanthropist Alfred E. Mann 15 years ago to support the development of biomedical technologies.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
› Verified 5 days ago
| Entity Name | Midwest Hospitalist Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891242319 PECOS PAC ID: 9830487966 Enrollment ID: O20200915000597 |
News Archive
Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
ARKRAY USA, Inc., a global leader of clinical chemistry, urine chemistry, and blood glucose products, today announced that it has re-introduced the CLIA waived DiaScreen® 50 Urine Chemistry Analyzer.
Wyatt Technology, the world leader in instrumentation for absolute macromolecular and nanoparticle characterization, reveals the launch of its 6th-generation Eclipse FFF system that represents an entirely new paradigm of FFF technology.
The Johns Hopkins University Applied Physics Laboratory, in Laurel, Maryland, has received $4 million in funding from the Mann Fund to develop a next-generation retinal prosthesis system. The Mann Fund was created by philanthropist Alfred E. Mann 15 years ago to support the development of biomedical technologies.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Markus Deleeuw, DO 509 N Madison St, Bloomfield, IA 52537-1271 Ph: (641) 664-3832 | Dr John Markus Deleeuw, DO 509 N Madison St, Bloomfield, IA 52537-1271 Ph: (641) 664-3832 |
News Archive
Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
ARKRAY USA, Inc., a global leader of clinical chemistry, urine chemistry, and blood glucose products, today announced that it has re-introduced the CLIA waived DiaScreen® 50 Urine Chemistry Analyzer.
Wyatt Technology, the world leader in instrumentation for absolute macromolecular and nanoparticle characterization, reveals the launch of its 6th-generation Eclipse FFF system that represents an entirely new paradigm of FFF technology.
The Johns Hopkins University Applied Physics Laboratory, in Laurel, Maryland, has received $4 million in funding from the Mann Fund to develop a next-generation retinal prosthesis system. The Mann Fund was created by philanthropist Alfred E. Mann 15 years ago to support the development of biomedical technologies.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
› Verified 5 days ago
Dr. Robert Daniel Floyd, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 509 N Madison St., Bloomfield, IA 52537 Phone: 641-664-3832 Fax: 641-664-1857 |